Adage Capital Partners’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-450,000
| Closed | -$594K | – | 967 |
|
|
2023
Q1 | $594K | Hold |
450,000
| – | – | ﹤0.01% | 815 |
|
|
2022
Q4 | $761K | Hold |
450,000
| – | – | ﹤0.01% | 851 |
|
|
2022
Q3 | $833K | Hold |
450,000
| – | – | ﹤0.01% | 897 |
|
|
2022
Q2 | $1.38M | Hold |
450,000
| – | – | ﹤0.01% | 905 |
|
|
2022
Q1 | $3.25M | Hold |
450,000
| – | – | 0.01% | 868 |
|
|
2021
Q4 | $7.37M | Sell |
450,000
-550,000
| -55% | -$9M | 0.01% | 771 |
|
|
2021
Q3 | $9.95M | Hold |
1,000,000
| – | – | 0.02% | 685 |
|
|
2021
Q2 | $9.98M | Hold |
1,000,000
| – | – | 0.02% | 692 |
|
|
2021
Q1 | $9.96M | Buy |
+1,000,000
| New | +$9.96M | 0.02% | 676 |
|